Silicon Laboratories (NASDAQ:SLAB) Lowered to “Sell” Rating by StockNews.com

Silicon Laboratories (NASDAQ:SLAB) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Thursday.

Several other analysts have also recently weighed in on the stock. Barclays boosted their price objective on shares of Silicon Laboratories from $75.00 to $120.00 and gave the stock an “equal weight” rating in a research note on Friday, January 17th. Stifel Nicolaus boosted their price target on shares of Silicon Laboratories from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Monday, January 6th. KeyCorp upped their price objective on shares of Silicon Laboratories from $115.00 to $160.00 and gave the company an “overweight” rating in a research note on Wednesday, January 22nd. Benchmark reissued a “buy” rating and set a $160.00 target price on shares of Silicon Laboratories in a research note on Wednesday, March 12th. Finally, Needham & Company LLC reaffirmed a “buy” rating and set a $150.00 price target on shares of Silicon Laboratories in a research report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and six have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of “Hold” and an average target price of $136.20.

Silicon Laboratories Stock Performance

Shares of SLAB opened at $113.03 on Thursday. Silicon Laboratories has a 52 week low of $94.00 and a 52 week high of $160.00. The stock has a market capitalization of $3.67 billion, a price-to-earnings ratio of -19.03 and a beta of 1.15. The stock has a fifty day moving average of $136.65 and a 200-day moving average of $123.53.

Silicon Laboratories (NASDAQ:SLAB) last posted its earnings results on Tuesday, February 4th. The semiconductor company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). The firm had revenue of $166.25 million during the quarter, compared to the consensus estimate of $166.09 million. Silicon Laboratories had a negative return on equity of 10.46% and a negative net margin of 32.69%. The business’s quarterly revenue was up 91.4% on a year-over-year basis. During the same period last year, the company earned ($1.19) earnings per share. As a group, equities analysts forecast that Silicon Laboratories will post -0.97 EPS for the current year.

Insider Activity

In other Silicon Laboratories news, Director William G. Bock sold 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, January 22nd. The stock was sold at an average price of $140.77, for a total value of $281,540.00. Following the completion of the sale, the director now owns 32,115 shares of the company’s stock, valued at approximately $4,520,828.55. This trade represents a 5.86 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Navdeep S. Sooch sold 2,360 shares of the business’s stock in a transaction that occurred on Wednesday, February 5th. The shares were sold at an average price of $149.00, for a total value of $351,640.00. Following the sale, the director now owns 400,567 shares of the company’s stock, valued at approximately $59,684,483. This represents a 0.59 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 5,360 shares of company stock worth $782,610 in the last three months. Company insiders own 1.72% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently made changes to their positions in the business. Wealth Enhancement Advisory Services LLC increased its position in shares of Silicon Laboratories by 9.7% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 2,334 shares of the semiconductor company’s stock worth $290,000 after acquiring an additional 206 shares in the last quarter. Jefferies Financial Group Inc. bought a new stake in Silicon Laboratories during the 4th quarter worth approximately $1,303,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Silicon Laboratories by 18.0% in the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 95,477 shares of the semiconductor company’s stock worth $11,860,000 after purchasing an additional 14,552 shares during the last quarter. Squarepoint Ops LLC lifted its holdings in shares of Silicon Laboratories by 735.0% in the fourth quarter. Squarepoint Ops LLC now owns 54,935 shares of the semiconductor company’s stock valued at $6,824,000 after purchasing an additional 48,356 shares in the last quarter. Finally, Summit Partners Public Asset Management LLC purchased a new position in shares of Silicon Laboratories during the fourth quarter valued at approximately $2,857,000.

About Silicon Laboratories

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, Taiwan, and internationally. The company's products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the industrial Internet of Things (IoT), including industrial automation and control, smart buildings, access control, HVAC control, and industrial wearables and power tools; smart cities applications, such as smart metering, smart street lighting, renewable energy, electric vehicle supply equipment, and smart agriculture; commercial IoT applications, including smart lighting, asset tracking, electronic shelf labels, theft protection, and enterprise access points; smart home applications, comprising home automation/security systems, smart speakers, smart lighting, HVAC control, smart cameras, smart appliances, smart home sensing, smart locks, and window/blind controls; and connected health applications, including diabetes management, consumer health and fitness, elderly care, patient monitoring, and activity tracking; as well as in commercial building automation, consumer electronics, and medical instrumentation.